Novozymes AS (NZYM B):企業の財務・戦略的SWOT分析

◆英語タイトル:Novozymes AS (NZYM B) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C15614
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:55
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:デンマーク
◆産業分野:消費財
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥16,625見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥33,250見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥49,875見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Novozymes AS (NZYM B) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Novozymes AS (Novozymes) is a biotechnology company that produces, markets and sells industrial enzymes and microorganisms. The company provides enzymes for detergents, technical, food and feed industries. It supplies a range of microorganisms for use in agriculture, industrial cleaning and wastewater treatment; and bioinnovation solutions to minimize the CO2 emissions. Novozymes’s products also find applications in hand and automatic dishwashing soaps, laundry detergents and professional cleaning products. It conducts research and development (R&D), production, and sale and marketing operations through subsidiaries such as Novozymes BioAg SA, Novozymes Latin America Ltda, Novozymes BioAg AS and Novozymes Nederland BV. The company has operational presence across Europe, the Middle-East, Africa, North America, Asia-Pacific and Latin America regions. Novozymes is headquartered in Bagsvaerd, Denmark.

Novozymes AS Key Recent Developments

Feb 27,2019 Biodiesel Industry grows stronger with new additions
Jan 31,2019 Novozymes: Change to the board of directors
Oct 24,2018 Novozymes announces fiscal Q3 2018 results
Oct 24,2018 Satisfactory first nine months; 5% organic sales growth in Q3: Novozymes

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Novozymes AS – Key Facts
Novozymes AS – Key Employees
Novozymes AS – Key Employee Biographies
Novozymes AS – Major Products and Services
Novozymes AS – History
Novozymes AS – Company Statement
Novozymes AS – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Novozymes AS – Business Description
Business Segment: Agriculture and Feed
Overview
Performance
Business Segment: Bioenergy
Overview
Performance
Business Segment: Food and Beverages
Overview
Performance
Business Segment: Household Care
Overview
Performance
Business Segment: Technical and Pharma
Overview
Performance
Geographical Segment: Asia-Pacific
Performance
Geographical Segment: Denmark
Performance
Geographical Segment: Latin America
Performance
Geographical Segment: North America
Performance
Geographical Segment: Rest of Europe, Middle-East and Africa
Performance
R&D Overview
Novozymes AS – Corporate Strategy
Novozymes AS – SWOT Analysis
SWOT Analysis – Overview
Novozymes AS – Strengths
Novozymes AS – Weaknesses
Novozymes AS – Opportunities
Novozymes AS – Threats
Novozymes AS – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Novozymes AS, Recent Deals Summary
Section 4 – Company’s Recent Developments
Feb 27, 2019: Biodiesel Industry grows stronger with new additions
Jan 31, 2019: Novozymes: Change to the board of directors
Oct 24, 2018: Novozymes announces fiscal Q3 2018 results
Oct 24, 2018: Satisfactory first nine months; 5% organic sales growth in Q3: Novozymes
Aug 10, 2018: Novozymes announces interim report for H1 2018
Aug 10, 2018: Novozymes: Interim report for the first half of 2018
Jul 18, 2018: SciBac announces strain development project with Novozymes
Jul 13, 2018: Novozymes and Novo Nordisk sign log-term PPA with Vattenfall in Denmark
Feb 07, 2018: Group financial statement for 2017
Section 5 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Novozymes AS, Key Facts
Novozymes AS, Key Employees
Novozymes AS, Key Employee Biographies
Novozymes AS, Major Products and Services
Novozymes AS, History
Novozymes AS, Subsidiaries
Novozymes AS, Key Competitors
Novozymes AS, Ratios based on current share price
Novozymes AS, Annual Ratios
Novozymes AS, Annual Ratios (Cont...1)
Novozymes AS, Annual Ratios (Cont...2)
Novozymes AS, Interim Ratios
Novozymes AS, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Novozymes AS, Performance Chart (2014 - 2018)
Novozymes AS, Ratio Charts

★海外企業調査レポート[Novozymes AS (NZYM B):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • A&D Company Ltd (7745):企業の財務・戦略的SWOT分析
    Summary A&D Company Ltd (A&D Company) is a medical equipment company that manufactures, designs, develops, and distributes advanced measuring, controlling, monitoring, and testing instruments. The company’s products include powertrain testing systems, digital analog converter, DSP platform, model ba …
  • BMO Private Bank:企業の戦略・SWOT・財務情報
    BMO Private Bank - Strategy, SWOT and Corporate Finance Report Summary BMO Private Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • ROHM Co Ltd (6963):企業の財務・戦略的SWOT分析
    ROHM Co Ltd (6963) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Cellnet Group Ltd (CLT):企業の財務・戦略的SWOT分析
    Cellnet Group Ltd (CLT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Rich Pharmaceuticals Inc (RCHA):企業の財務・戦略的SWOT分析
    Summary Rich Pharmaceuticals Inc (Rich Pharmaceuticals) is a biopharmaceutical company that offers discovery and development of therapies for the treatment of acute myelogenous leukemia (AML) in refractory patients. The company’s pipeline portfolio offers a lead drug candidate for the treatment of a …
  • Naspers Limited:企業の戦略・SWOT・財務情報
    Naspers Limited - Strategy, SWOT and Corporate Finance Report Summary Naspers Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Pulmonx Corp:医療機器:M&Aディール及び事業提携情報
    Summary Pulmonx Corp (Pulmonx) is a medical device company that manufactures and markets minimally invasive medical devices and technologies for the diagnosis and treatment of pulmonary disorders. The company uses combination of assessment tools and therapeutics which enables physicians to successfu …
  • Continental AG:企業の戦略・SWOT・財務分析
    Continental AG - Strategy, SWOT and Corporate Finance Report Summary Continental AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Advanced Micro Devices Inc (AMD):企業の財務・戦略的SWOT分析
    Advanced Micro Devices Inc (AMD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Carl Zeiss Meditec Inc.:医療機器:M&Aディール及び事業提携情報
    Summary Carl Zeiss Meditec Inc (Carl Zeiss Meditec), a subsidiary of Carl Zeiss Meditec AG is a medical technology company that manufactures and markets various healthcare products. The company provides ophthalmology and optometry products, neurosurgery products, ENT products, spine surgery products …
  • Heartland Consumers Power District:企業の戦略的SWOT分析
    Heartland Consumers Power District - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Australian Mines Limited:企業の戦略・SWOT・財務分析
    Australian Mines Limited - Strategy, SWOT and Corporate Finance Report Summary Australian Mines Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • ContourGlobal LP-エネルギー分野:企業M&A・提携分析
    Summary ContourGlobal L.P. (CGLP) is an energy company that owns and operates of power generation assets. It develops, acquires and operates electric power and district heating businesses. The company develops and operates large central power plants in emerging markets to support the growth of the n …
  • Opus International Consultants Ltd:企業の戦略・SWOT・財務情報
    Opus International Consultants Ltd - Strategy, SWOT and Corporate Finance Report Summary Opus International Consultants Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Xiwang Special Steel Company Limited:企業の戦略・SWOT・財務情報
    Xiwang Special Steel Company Limited - Strategy, SWOT and Corporate Finance Report Summary Xiwang Special Steel Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • QUALCOMM Incorporated:企業の戦略・SWOT・財務情報
    QUALCOMM Incorporated - Strategy, SWOT and Corporate Finance Report Summary QUALCOMM Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Canada Life Ltd:企業の戦略・SWOT・財務情報
    Canada Life Ltd - Strategy, SWOT and Corporate Finance Report Summary Canada Life Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Mayne Pharma Group Ltd (MYX):企業の財務・戦略的SWOT分析
    Summary Mayne Pharma Group Ltd (Mayne Pharma), formerly HalcyGen Pharmaceuticals Ltd, a subsidiary of Mayne Pharma Group Ltd, is a specialty pharmaceutical company that manufactures and markets branded and generic medicinal products. The company’s products comprise erymax capsules, kapanol capsules, …
  • Lantern Pharma Inc-製薬・医療分野:企業M&A・提携分析
    Summary Lantern Pharma Inc (Lantern Pharma) is a drug development company that discovers and develops therapies for various cancer types. The company’s pipeline products include Irofulven-1, an anti-tumor agent is developed to fight against multi-drug resistant cancers. Its Irofulven-1 is used for t …
  • PharmaEssentia Corp (6446):製薬・医療:M&Aディール及び事業提携情報
    Summary PharmaEssentia Corp (PharmaEssentia) is a developer of therapeutic products for the treatment of human diseases. The company’s pipeline product includes P1101, a new generation PEG-Interferon-alpha-2b which is developed using PEGylation technology platform. Its pegylation technology platform …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆